It was shown that the use of aptamers as a targeting agent for imaging prostate tumor cells using QDs was equally efficient as using QDs conjugated to anti-PSMA-antibodies, but considerably less expensive [35]. The gene discussed is FOLH1; the disease is prostate neoplasm.